[TPI and FTA tests in the evaluation of effectiveness of the oral treatment of early symptomatic syphilis with detreomycin, erythromycin and oxytetracycline with consideration of the clinical picture].
D002701:Chloramphenicol / Q000627:therapeutic use*; D004917:Erythromycin / Q000627:therapeutic use*; D005455:Fluorescent Antibody Technique; D005500:Follow-Up Studies; D006801:Humans; D010118:Oxytetracycline / Q000627:therapeutic use*; D013587:Syphilis / Q000188:drug therapy*; D014209:Treponema Immobilization Test
D004917:Erythromycin; D002701:Chloramphenicol; D010118:Oxytetracycline
Odczyny T.P.I. i E.T.A. w ocenie skuteczności doustnegó leczeniá kiły wczesnej objawowej detreomycyna, erytromycyna i oksyterracyna z uwzglednieniem obrazu klinicznego.